• WE ARE
    • We Are Early Phase
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • Management
  • EARLY PHASE
    • First-in-Human
    • Interaction
    • Inhalation
    • Infusion & injection
    • Cardiac safety
    • Pharmacology
    • Consultancy
    • Medical writing
    • Data management
  • INDICATIONS
    • Cardiometabolics
    • Dermatology
    • Women‘s Health
    • Hemostaseology
    • Hepatology
    • Pulmology
    • Renal Impairment
    • Vaccines
    • Your individual request
  • SCIENCE
  • WORK WITH US
  • WE ARE
    • We Are Early Phase
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • Management
  • EARLY PHASE
    • First-in-Human
    • Interaction
    • Inhalation
    • Infusion & injection
    • Cardiac safety
    • Pharmacology
    • Consultancy
    • Medical writing
    • Data management
  • INDICATIONS
    • Cardiometabolics
    • Dermatology
    • Women‘s Health
    • Hemostaseology
    • Hepatology
    • Pulmology
    • Renal Impairment
    • Vaccines
    • Your individual request
  • SCIENCE
  • WORK WITH US

A Thorough QT Study of Teduglutide in Healthy Subjects.

Science 20. April 2020
ShareTwitterFacebookXingLinkedin

Teduglutide, an analog of the endogenous hormone glucagon-like peptide-2, is currently being developed for the treatment of short bowel syndrome.

Read Article

Pharmacokinetics, Tolerability, and Safety of Murepavadin, a Novel Antipseudomonal Antibiotic, in Subjects with Mild, Moderate, or Severe Renal Function Impairment.

Science 20. April 2020
ShareTwitterFacebookXingLinkedin

This open-label, nonrandomized, single-dose, phase 1 study evaluated the pharmacokinetics and safety of murepavadin, a novel peptide antibiotic for the treatment of serious Pseudomonas aeruginosa infections.

Read Article

Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial.

Science 20. April 2020
ShareTwitterFacebookXingLinkedin

Dulaglutide and liraglutide, both glucagon-like peptide-1 (GLP-1) receptor agonists, improve glycaemic control and reduce weight in patients with type 2 diabetes. I

Read Article

Sequential Treatment Escalation with Dapagliflozin and Saxagliptin Improves Beta Cell Function in Type 2 Diabetic Patients on Previous Metformin Treatment: An Exploratory Mechanistic Study.

Science 20. April 2020
ShareTwitterFacebookXingLinkedin

We investigated the effect of sequential treatment escalation with dapagliflozin and saxagliptin on beta cell function in patients with T2DM insufficiently controlled on metformin monotherapy during a hyperglycaemic clamp investigation.

Read Article

Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.

Science 19. März 2020
ShareTwitterFacebookXingLinkedin

Basal insulin peglispro (BIL) has a peripheral-to-hepatic distribution of action that resembles endogenous insulin and a prolonged duration of action with a flat pharmacokinetic/pharmacodynamic profile at steady …

Read Article

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial.

Science 19. März 2020
ShareTwitterFacebookXingLinkedin
First published in Journal Diabetes care on 2017 JanDiabetes Care. 2017 Jan;40(1):63-68. doi: 10.2337/dc16-1525. Epub 2016 Nov 4
Read Article

Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patients.

Science 18. März 2020
ShareTwitterFacebookXingLinkedin
First published in Endocrine. 2017 Apr/ Endocrine. 2017 Apr56(1):158-163. doi: 10.1007/s12020-016-1179-z. Epub 2016 Nov 30
Read Article

Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.

Science 18. März 2020
ShareTwitterFacebookXingLinkedin
First published in John Wiley & Sons Ltd., Diabetes obesity and metabolism on 2017 Apr.Diabetes Obes Metab. 2017 Apr;19(4):489-495. doi:...
Read Article

Impact of Injection Speed, Volume, and Site on Pain Sensation

Science 18. März 2020
ShareTwitterFacebookXingLinkedin
First published in Journal of Diabetes Science and Technology on 2018 JanJ Diabetes Sci Technol. 2018 Jan;12(1):163-168. doi: 10.1177/1932296817735121. Epub...
Read Article

Acceptability of Implantable Continuous Glucose Monitoring Sensor

Science 18. März 2020
ShareTwitterFacebookXingLinkedin
First published in Journal of Diabetes Science and Technology on 2018 MayJ Diabetes Sci Technol. 2018 Jan;12(1):163-168. doi: 10.1177/1932296817735121. Epub...
Read Article

Beitrags-Navigation

Page 1 Page 2 >
QUICK LINKS
  • WE ARE
    • In a Nutshell
    • Our History
    • Facilities
    • Values
    • MANAGEMENT
  • EARLY PHASE
    • First-in-human
    • Cardiac safety
    • Infusion & injection
    • Inhalation
    • Pharmacology
    • Interaction
    • Consultancy
    • Medical Writing
    • Data Management
.
  • INDICATIONS
    • Cardiometabolics
    • Dermatology
    • Women‘s Health
    • Hemostaseology
    • Hepatology
    • Pulmology
    • Renal Impairment
    • Vaccines
    • Your individual request
  • SCIENCE
  • WORK WITH US
EXPERTISE
  • Consultancy
  • Medical Writing
  • Early Phase
FACILITIES
  • Berlin
  • Kiel
  • Mannheim
  • Wuppertal
FÜR PROBANDEN
  • ÜBER STUDIEN
  • AN STUDIEN TEILNEHMEN
LEGAL
  • PRIVACY
  • IMPRINT
  • DISCLAIMER
  • —
  • Work with us
    • CURRENT JOB
    • OPPORTUNITIES
Copyright © 2021 CRS. Experts. Early Phase. All rights reserved.